InvestorsHub Logo
Followers 22
Posts 1317
Boards Moderated 0
Alias Born 10/27/2015

Re: 6pack2go post# 57607

Friday, 04/14/2017 2:20:37 PM

Friday, April 14, 2017 2:20:37 PM

Post# of 194357
Where to start yet again?

1. Armen isn't the CEO, and they have audited financials. Next?

2. Being licensed to fill prescriptions from other states "does nothing to increase script count and gain more revenue"? Okay... that's just adorable. Next?

3. They've maintained double-digit % YOY script count and revenue increases throughout 2016 and 2017, even during their busiest months. Next?

4. I suspect they meant they could begin taking the steps (additional audit years, etc.) to uplist to NASDAQ at any time, and that there's nothing in their fundamentals that would prevent it. (That would have been a good question to ask at the recent CC. Why didn't you?) Next?

5. No idea. Don't care. The 3rd-party-audited 2016 financials tell me about the business I'm investing in, not the number of shareholders. Next?

6. And what part of RXMD's year-over-year growth, profitability, and audited financials is responsible for that?

7. "The company is not SEC reporting and is using the Alternative method which is commonly used by many penny stocks." Fixed that. Next?

8. 2016's financials are audited, so regardless, we know their values are accurate. Maybe their existing fleet depreciated in value more than the value of the new vehicles. Maybe they had to use a different accounting procedure in the 2016 financials. Next?

9. RXMD is a penny stock that has a positive profit margin? That's amazing! How often do you see that! Thanks for pointing that out! (Question: would you suggest RXMD grow by sitting on their money instead of spending it to expand their operations?) Next?

10. Yep, that's a pharmacist who brought clients over from a previous job and is getting a % of the business brought over. Next?

11. Question: How do you know how many shares MIDAM has sold, or what their total position in RXMD is? Next?

12. And this has what to do with RXMD's fundamentals? Nothing? Huh. Interesting. Next?

13. Again, what does this have to do with RXMD as a company? Nothing? Huh. Next?

14. Name one multi-national corporation that started out as a multi-national corporation. Is there even a point here? Next?

Nothing? Well, this was fun (and super on-topic!)...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News